SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-24-000837
Filing Date
2024-01-31
Accepted
2024-01-31 16:10:13
Documents
1
Group Members
PATRICK G. G. DEARREADE E. GRIFFITHTETRAGON FINANCIAL GROUP LTDTETRAGON FINANCIAL MANAGEMENT L.P.

Document Format Files

Seq Description Document Type Size
1 AUTOLUS THERAPEUTICS PLC p24-0102sc13ga.htm SC 13G/A 86197
  Complete submission text file 0000902664-24-000837.txt   88065
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90550 | Film No.: 24582981
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 399 PARK AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 359-7300
Tetragon Financial Management LP (Filed by) CIK: 0001758892 (see all company filings)

IRS No.: 203311552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A